To include your compound in the COVID-19 Resource Center, submit it here.
Rubius Therapeutics Inc. (Cambridge, Mass.) said it raised $100 million in an untranched
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury